Atlas Trials

Phase 3 Study to Evaluate the Acid-Inhibitory Effect of Multiple Oral Doses of Vonoprazan (TAK-438)

Clinical trial NCT02037477 · COMPLETED

Trial details

NCT number
NCT02037477
Sponsor
Takeda
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2014-01-01
Primary completion
2014-03-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.